The US Consumer Product Safety Commission (CPSC) has requested that the industry set voluntary limits for the presence of cadmium in children’s toys and jewelry. Following months of testing by agency scientists that indicated it is dangerous for children to ingest small amounts of cadmium, the CPSC has urged ASTM International to update its safety […]
A study conducted by Roland Berger of 50 top drug industry executives showed a pattern of large pharmaceutical companies moving away from development of patented drugs as concern about the returns from future innovation mounts. The survey showed significantly different approaches to diversification, with 67% viewing diversification as a potential solution. France’s Sanofi-Aventis is among […]
Strong third-quarter corporate earnings and future quantitative easing expectations boosted major US markets in October. The Dow Jones Industrial Average, S&P 500 and NASDAQ gained 3.1%, 3.7% and 5.9%, respectively. Unfortunately, higher profits have been spurred by restructuring initiatives, including reduced employment and restrained spending, defying support for economic growth. On October 29, the Commerce […]
Singapore 10/29/10—Agilent Technologies has opened a life sciences instrument manufacturing facility in Singapore to produce its LC/MS systems. The facility will produce the company’s 6100 series Single Quadrupole LC/MS, 6200 series Accurate-Mass Quadrupole TOF LC/MS, 6400 series Triple Quadrupole LC/MS and 6500 series Accurate-Mass Quadrupole TOF LC/MS. “Singapore is the ideal location for this facility […]
London, England 10/21/10—RTS Life Science, a provider of laboratory sample management solutions, will be sold to Entologi for £600,000 ($946,536 = £0.63 = $1) in cash, under a proposal to shareholders by publicly held parent company Robotic Technology Systems (RTS). RTS’s other businesses, RTS Flexible Systems and RTS Thurnall, will also be sold to Entologi. […]
Cambridge, MA 10/25/10—Helicos BioSciences has amended its patent infringement suit against Pacific Biosciences (see IBO 9/30/10), naming Illumina and Life Technologies as additional defendants. The suit alleges willful infringement of four patents for sequencing-by-synthesis methods using labeled nucleotides. “After a careful examination of the sequencing products and technologies offered by Illumina and Life Technologies, we […]
Menlo Park, CA 10/26/10; Washington, DC 10/26/10; New York, NY 10/27/10—DNA sequencer developer Pacific Biosciences completed its IPO (see IBO 8/31/10, 10/15/10) on October 26, selling 12.5 million shares of its common stock at $16 per share, which was the mid-range of its pricing. The sale raised $200 million, according to an SEC filing. Shares […]
Isothermal titration calorimetry (ITC), reaction calorimetry and differential scanning calorimetry (DSC) are the three main types of calorimetry, which passively measures changes of state or the formation of aqueous solutions. ITC currently accounts for more than a quarter of the calorimetry market. ITC initial system sales grew an estimated 11% in 2009. Its sales are […]
It was a little more than a year ago that Danaher announced the acquisition of Life Technologies’ MS business and MDS Analytical Technologies, including Molecular Devices (see IBO 9/15/10). The acquisition introduced a new player into the MS market and expanded Danaher’s business in the life science research instrument market. With 2009 revenues in excess […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
